Central Laboratory, The Affiliated Hospital of Qingdao University, 1677 Wutaishan Road, Qingdao, 266555, China.
Department of Nephrology, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao, 266003, China.
BMC Nephrol. 2018 Dec 17;19(1):364. doi: 10.1186/s12882-018-1173-1.
Distal renal tubular acidosis (dRTA) is a heterogeneous disorder characterized by normal anion gap metabolic acidosis. Autosomal recessive dRTA is usually caused by mutations occurring in ATP6V1B1 and ATP6V0A4 genes,encoding subunits B1 and a4 of apical H-ATPase, respectively. The heterogeneous clinical manifestations of dRTA have been described in different ethnic groups harboring distinct mutations. Most of the reported cases are from Europe and Africa. At present, the prevalence of primary dRTA is still poorly elucidated in Chinese population.
A 2-year and six-month-old female patient was hospitalized because of recurrent hypokalemia, hyperchloremic metabolic acidosis and growth retardation. Laboratory investigations presented a normal anion gap hyperchloremic metabolic acidosis, hypokalemia, and inappropriate alkaline urine. Renal ultrasound indicated bilateral nephrocalcinosis. Bilateral sensorineural hearing loss (SNHL) was confirmed with moderately severe (45 dB) on the left ear and severe (80 dB) on the right ear, which was accompanied with enlarged vestibular aqueduct (EVA) on both sides. According to these findings, a diagnosis of dRTA was made. To identify the pathogenic gene mutation, all coding regions of ATP6V1B1 and ATP6V0A4 gene, including intron-exon boundaries, were analyzed using PCR followed by direct sequence analysis. The splicing variants were verified in peripheral blood leucocytes of the patient by RT-PCR. As a result, two novel heterozygous mutations in ATP6V1B1 were identified in the child. One mutation was a successive 2-nucleotide deletion in exon 2(c.133-134delTG), which caused a marked nonsense mediated mRNA decay. The other was a guanine to adenine substitution of the first nucleotide of intron 8(c.785 + 1 G > A), which led to the exclusion of exon 8. After treatment with sodium citrate, potassium citrateand citric acid, metabolic acidosis and hypokalemia were corrected, but her hearing decreased gradually during the 2 years and had to accept the use of bilateral hearing aids.
We described two novel dRTA associated mutations in ATP6V1B1 identified in a Chinese child patient accompanying with SNHL and EVA. Our study will help to expand the understanding of this rare disease in Chinese population.
远端肾小管性酸中毒(dRTA)是一种表现为正常阴离子间隙代谢性酸中毒的异质性疾病。常染色体隐性遗传型 dRTA 通常由 ATP6V1B1 和 ATP6V0A4 基因突变引起,分别编码顶膜 H+-ATP 酶的亚基 B1 和亚基 a4。在不同携带不同突变的种族中,dRTA 的异质性临床表现已有描述。大多数报道的病例来自欧洲和非洲。目前,中国人原发性 dRTA 的患病率仍不清楚。
一名 2 岁 6 个月大的女性因反复低钾血症、高氯性代谢性酸中毒和生长迟缓而住院。实验室检查结果为正常阴离子间隙性高氯性代谢性酸中毒、低钾血症和不适当的碱性尿液。肾脏超声显示双侧肾钙质沉着症。双侧感音神经性听力损失(SNHL),左耳中度严重(45dB),右耳严重(80dB),双侧前庭导水管扩大(EVA)。根据这些发现,诊断为 dRTA。为了确定致病基因突变,使用 PCR 直接测序法分析了 ATP6V1B1 和 ATP6V0A4 基因的所有编码区,包括内含子-外显子边界。通过 RT-PCR 验证了患者外周血白细胞中的剪接变异体。结果,在患儿中发现了 ATP6V1B1 中的两个新的杂合突变。一个突变是外显子 2 中连续的 2 个核苷酸缺失(c.133-134delTG),导致明显的无意义介导的 mRNA 衰减。另一个是内含子 8 第一个核苷酸的鸟嘌呤到腺嘌呤取代(c.785+1G>A),导致外显子 8 的缺失。经过枸橼酸钠、枸橼酸钾和柠檬酸治疗后,代谢性酸中毒和低钾血症得到纠正,但她的听力在 2 年期间逐渐下降,不得不使用双侧助听器。
我们描述了一名中国患儿的 ATP6V1B1 中两个新的 dRTA 相关突变,该患儿伴有 SNHL 和 EVA。我们的研究将有助于增加对中国人群中这种罕见疾病的认识。